Sling Therapeutics Appoints Andrew Guggenhime To Its Board Of Directors
(MENAFN- PR Newswire) ANN ARBOR, Mich., Jan. 7, 2025 /PRNewswire/ -- Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED), today announced …